Release #:812-181660-rl-1169862: LETTER TO

New Post Public Reply Private Reply Replies (0) Message Board
iwantutowantBIEL rwh01 #1768
808
Release #:812-181660-rl-1169862:


LETTER TO STOCKHOLDERS- July 2, 2019
FDA Market Clearances Update
Post-Operative Pain
On Friday, June 28th, we received market clearance from the US FDA for RecoveryRx® (https://www.accessdata.fda.gov/scripts/cdrh/cfdocs/cfpmn/pmn.cfm?ID=K190251). A press release announcing the same was issued on Monday, July 1 (https://www.globenewswire.com/news-release/2019/07/01/1876675/0/en/BioElectronics-Announces-FDA-Market-Clearance-for-Its-Non-Opioid-Postoperative-Pain-Therapy.html).
The Company is in discussions with two major organizations to rollout the RecoveryRx product in the US. Additionally, we are working to list the product with three major drug wholesalers (McKesson Corporation, Cardinal Health and Smith Drug).
Musculoskeletal Pain 510(k)
BioElectronics is currently preparing documentation to file its 510(k) application to seek expanded indications of musculoskeletal pain, using the cervical osteoarthritis (neck pain) study. We are waiting for the full data set from the study investigator and expect to file the 510(k) application within a few weeks.
ActiPatch® is already FDA-cleared for adjunctive treatment of pain from knee osteoarthritis (25 million) and plantar fasciitis (2 million annually). The expanded market clearance would allow ActiPatch to be marketed for millions of Americans suffering with a broad range of musculoskeletal conditions: back pain (42 million), neck pain (19 million), hip pain (9 million), shoulder pain (11 million), carpal tunnel pain (12 million) and many other musculoskeletal complaints.
The neck osteoarthritis study investigates the effectiveness of ActiPatch in reducing pain both in men and women and satisfies the FDA requirement for a third ActiPatch study on a different musculoskeletal location to get general musculoskeletal clearance, thus serving as a replacement for the back-pain study. The neck study directly compares the effectiveness of ActiPatch to that of prescription NSAID pills. Subjects were randomly assigned either to receive the standard of care treatment (cox-2 inhibitor) or ActiPatch. Interim results demonstrate that the ActiPatch is statistically significantly superior to the prescription NAID drug in reducing neck pain.
CE Mark Status Update
The ISO certification process at our manufacturer’s facility is going on briskly, while the technical review process with the notified body is nearing completion. The ISO certification, along with the technical file review comprise the two parts required to meet current CE mark requirements.
Mr. Bill Monn, who retired as VP of Logistics/Production at BioElectronics in 2018, is working with us as a consultant to assist in timely completion of the CE mark project.
Sales and Marketing Development
1. Walmart. The Walmart meeting went really well. At this point we have been asked by the buyer to show a couple things of interest. The item is very well received, and they have a desire to find product to fill a need in pain management for patients looking for alternatives to therapies that are not working. Mostly NSAIDs and opioids. The buyer has asked us to demonstrate our ability to drive sales through Walmart.com and then have another discussion at the end of September or August. We were one of thousands of companies to meet with this buyer for a 30-minute appointment. This appointment is no different than any other appointment where you as a vendor are asked to attend. There is interest here given our ability to prove in the market a product.
2. ActiPatch has been available through Performance Health on DSSI for the last few months for HCR ManorCare facilities. A presentation about ActiPatch was presented at their corporate meeting with upper business managers/operators. There was a lot of positive interest and they felt that they would soon facilitate adoption of ActiPatch into their centers. HCR ManorCare was happy to report that the product training went extremely well, and they have many therapists and patients “singing the praises” of the products. They have been ordering consistently in most of their centers and are happy to see their therapists offering ActiPatch as a treatment option for pain relief.
3. Endonovo Therapeutics, Inc. makers of a pulsed electromagnetic device has filed a lawsuit alleging we have violated their patents which were issued 2 years after our new patents. The lawsuit was filed in the Federal District Court in Los Angeles, California. We have retained an experienced patent litigator to file our response and to dispose of the case.
Disclosure: This newsletter is part of the bimonthly investor update; BioElectronics Corporation will be sending out this publication on the 1st and 16th (or the closest Monday) of every month. If you have further questions, please email investors@bielcorp.com.

BioElectronics Corporation (BIEL) Stock Research Links

BIEL Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Early Therapy After Sports Injuries Deserves Careful Timing

Updated Category News Views 80

A limp can become a bad habit long before an athlete calls it one. That is the plain, useful concern behind Dr. Kali Spoto LaRue's discussion of sports-injury physical therapy for athletes in Fairport and Greater Rochester. The central message is not that every sore muscle needs the same response, nor that anybody should charge back into practice because they had one...

Continue Reading
SDG&E's 21-Year Reliability Run Has Real Investor Weight

Updated Category News Views 56

Seventy minutes without power in a year is the sort of number most people ignore until their refrigerator quits humming. For San Diego Gas & Electric customers, though, it is a meaningful operating result: roughly 70 minutes annually from unplanned outages, on average, over the past decade, alongside fewer than one sustained outage per customer each year. SDG&E has also...

Continue Reading
Robert Half's Parent Support Earns Fortune Recognition

Updated Category News Views 114

A workplace award rarely moves a staffing stock by itself, and it shouldn’t. Still, Fortune naming Robert Half among its Best Workplaces for Parents for 2026 is more than decorative corporate wallpaper. In the talent business, the company’s own ability to recruit, retain and support people is part of the product. Clients hire Robert Half because they need skilled...

Continue Reading
Why Professional Collaboration May Matter More in AI

Updated Category News Views 51

Three smart professionals can still hand a client a mess when nobody owns the handoff. That unglamorous reality sits behind the Professional Collaboration Institute, or PCI, which Sarano and Brooke Kelley plan to launch in a virtual briefing on December 2. The outfit wants to turn cross-profession coordination into a teachable, measurable discipline rather than leave it...

Continue Reading
First Grade Literacy Push Deserves a Harder Look Now

Updated Category News Views 146

A reading gap can become a concrete wall before anyone bothers measuring it. That is the uncomfortable point behind Ignite Reading's First Grade Promise, and it deserves more attention than another polished education announcement usually gets. At a Nov. 5 Convene 2026 gathering in Boston, 56 district and literacy leaders from six states focused on getting children reading...

Continue Reading
Alphabet Lawsuit Puts Gemini Delays Under a Microscope

Updated Category News Views 189

July’s twin punches to Alphabet shares were not the sort of wobble investors can casually shrug off. First came a report on July 16 that Google was months behind on Gemini 3.5 Pro, its flagship AI model, after disappointing results from updated training data. Then came the harder financial reality a week later: a much larger 2026 capital-spending plan, negative...

Continue Reading
Home Nursing Plans Need Clarity Before the Next Crisis

Updated Category News Views 16

A medication change scribbled on a loose sheet can become a very long night. That is the unglamorous truth behind the discussion from Michael and Marsha Reda of Aurora Home Care in Williamsville, New York: long-term home nursing care depends on a plan people can actually follow when the household is tired, worried, and juggling too much. Their perspective, featured by...

Continue Reading
Carnival Maps a Longer, Broader Bet on Cruise Demand

Updated Category News Views 36

A cruise operator does not order ships for 2035 because it is feeling timid. Carnival is laying out a long runway of hardware, private-destination capacity and onboard-to-onshore spending hooks, all aimed at keeping guests inside its ecosystem longer. For NYSE:CCL, this is not a next-quarter story. It is a very public statement that management sees enduring appetite for...

Continue Reading
Specialized Metal Makers Become the New M&A Prize Again

Updated Category News Views 44

A forgotten heat-treatment line can suddenly be worth more than a shiny new mill when buyers realize nobody can duplicate its certifications, workforce, and customer approvals overnight. That is the basic truth sitting underneath BGL's Nov. 19, 2026 assessment of the U.S. metals market. The easy headline is consolidation. The useful takeaway is much narrower: specialized...

Continue Reading
PPL's January Dividend Keeps Utility Appeal Intact

Updated Category News Views 17

A dividend notice is rarely thrilling, but it can still separate a steady utility from a story stock peddling fumes. PPL Corporation declared a quarterly common dividend of $0.2850 per share on Nov. 20, payable Jan. 4, 2027. Shareholders must be on the books by Dec. 10, 2026, to receive it. Plain vanilla stuff, yes. Still, plain vanilla is often precisely why utility...

Continue Reading

Top 5 Most Recently Viewed Articles

Exploring the Expanding Scope of Implantable Medical Devices

Updated Category News Views 122

Overview of the Implantable Medical Devices Market The global market for implantable medical devices is witnessing remarkable growth, with projections estimating it to reach approximately USD 176.33 billion by 2034, escalating at a compound annual growth rate (CAGR) of 6.14%. This rise is largely influenced by a steadily increasing prevalence of chronic diseases and an...

Continue Reading
Revolutionizing Home Financing: The Launch of Rate Intelligence

Updated Category News Views 109

Rate's Innovative AI Solution for Mortgage Lending Rate, a pioneer in financial technology, has recently introduced Rate Intelligence—an advanced AI platform that seeks to redefine the mortgage experience for both homebuyers and loan officers. By leveraging cutting-edge technology, Rate is on a mission to enhance efficiency, speed, and accuracy in the home financing...

Continue Reading
Lindahl Reed Secures OASIS+ Contracts to Enhance Services

Updated Category News Views 163

Lindahl Reed Achieves Significant OASIS+ Contract Awards Lindahl Reed, Inc., a prominent player in the technical and scientific services arena, has recently been awarded the One Acquisition Solution for Integrated Services Plus (OASIS+) – 8(a) and Women-Owned Small Business (WOSB) Multi-Agency Contract master contracts. This new development is noteworthy as it allows...

Continue Reading
Safe Bulkers (NYSE: SB) Sees 52-Week Low Amid Market Struggles

Updated Category News Views 334

Safe Bulkers (NYSE: SB) Faces Market Challenges In a challenging environment for investors, Safe Bulkers Inc. (NYSE: SB) has witnessed its stock drop to a 52-week low, currently standing at $3.4. This decline highlights the broader issues prevalent in the shipping sector, where shifts in demand and fluctuating shipping rates have placed pressure on many companies,...

Continue Reading
Emerging Cybersecurity Trends for 2026: AI's Dual Role

Updated Category News Views 280

Understanding 2026: Cybersecurity Predictions and Insights In an era where technology is evolving at a rapid pace, organizations find themselves at a critical juncture. The proliferation of AI poses both unprecedented opportunities and significant threats. Businesses must stay vigilant against a historic wave of DNS exploitation alongside an evolving threat landscape. As...

Continue Reading